Global Ainuovirine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Ainuovirine market size was valued at US$ 43.32 million in 2025 and is forecast to a readjusted size of US$ 119 million by 2032 with a CAGR of 9.9% during review period.
In 2025, global Enovelin production reached approximately 460,000 units.Enovelin is a novel small-molecule antiviral agent primarily used for the treatment of viral infectious diseases, with potential applications particularly in respiratory viruses and other RNA virus infections. Its mechanism of action generally involves inhibiting key enzymes required for viral replication or interfering with viral nucleic acid synthesis, thereby blocking viral replication and spread within host cells.
Compared with traditional antiviral drugs, enovelin demonstrates certain advantages in terms of sustained efficacy, safety, and resistance control, while also offering convenient oral administration and high bioavailability. In clinical studies or applications, the drug has shown favorable antiviral activity and tolerability, indicating its potential to establish a role in antiviral therapy.Overall, as a novel antiviral candidate, enovelin shows promising prospects in addressing viral infections.
Ainuovirine (Enovelin), as a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) independently developed in China, is primarily positioned in the HIV antiviral treatment market. With the global population living with HIV remaining at a high level, the demand for antiretroviral therapy (ART) continues to be stable and steadily growing, particularly in developing countries and emerging markets, where there is a strong need for new drugs with high efficacy, safety, and low resistance. Ainuovirine demonstrates strong antiviral activity, low cross-resistance, and fewer drug–drug interactions, providing a differentiated competitive advantage within existing treatment regimens.
From a competitive perspective, the current HIV treatment market is dominated by integrase strand transfer inhibitors (INSTIs) and traditional NNRTIs (such as efavirenz). However, some of these drugs are associated with metabolic side effects or resistance issues, leading to renewed interest in next-generation NNRTIs. As a domestically developed innovative drug, ainuovirine was approved for marketing in 2021 and has been included in treatment guidelines and reimbursement systems, facilitating its rapid uptake in the Chinese market. In addition, its once-daily oral administration and favorable tolerability provide advantages in long-term chronic disease management.
This report is a detailed and comprehensive analysis for global Ainuovirine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ainuovirine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ainuovirine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ainuovirine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ainuovirine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ainuovirine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ainuovirine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Aidea Pharmaceutical, Yangzhou Aidea Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ainuovirine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hospital
Retail
Online
Market segment by Specification
8mg/capsule
12 mg/capsule
Market segment by Dosage form
Tablets
Powder
Market segment by Application
Treatment of HIV-1 infection
Antiviral Therapy
Others
Major players covered
Jiangsu Aidea Pharmaceutical
Yangzhou Aidea Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ainuovirine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ainuovirine, with price, sales quantity, revenue, and global market share of Ainuovirine from 2021 to 2026.
Chapter 3, the Ainuovirine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ainuovirine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ainuovirine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ainuovirine.
Chapter 14 and 15, to describe Ainuovirine sales channel, distributors, customers, research findings and conclusion.